Skip to main content
. 2022 Sep 29;21(11):100421. doi: 10.1016/j.mcpro.2022.100421

Table 2.

Patient characteristics for all samples collected

Patient characteristics All samples (n = 96) Gastritis ≤1 (n = 54) Gastritis ≥2 (n = 42)
Female (%/number) 78%/n = 75 76%/n = 41 81%/n = 34
Age (mean/median/range) 41.1/42.0/19–64 42.6/44.0/19–64 39.3/39.5/24–59
Body mass index (kg/m2,, mean/median/range) 39.91/39.20/32.70–53.50 40.28/39.55/32.70–53.50 39.43/39.00/34.00–48.90
Obesity (%) 100 100 100
Healthy (apart from obesity, %/number) 31%/n = 30 30%/n = 16 33%%/n = 14
Diabetes (type 1 or 2, %/number) 10%/n = 10 7%/n = 4 14%/n = 6
Proton pump inhibitor treatment (%/number) 9%/n = 9 6%/n = 3 14%/n = 6
Gastritis (histology score 0–5, mean/median/interquartile range) 1.47/1.00/2.00 0.44/0.00/1.00 2.79/2.50/1.00
Leb (histology score 0–5, mean/median/interquartile range) 1.54/2.00/2.00 1.30/1.00/2.00 1.86/2.00/2.00a

Representative images for the Leb staining are shown in supplemental Fig. S1.

a

The Leb scores among patients with gastritis scores ≤1 were lower than from those with gastritis scores ≥2, Mann–Whitney U test, p < 0.05. Means and medians are presented together to nuance the data where applicable. The data presented as % were analyzed with Chi-square test, but no differences were significant between groups.